San Diego, CA, United States of America

Anita Difrancesco

This inventor holds 3 USPTO granted patents. Top assignee: Endeavor Biomedicines, Inc.. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anita Difrancesco. Retrieved from https://idiyas.com/inventor/anita-difrancesco

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Anita Difrancesco: Innovator in Fibrosis Treatment

Introduction

Anita Difrancesco is a prominent inventor based in San Diego, California. She has made significant contributions to the field of medicine, particularly in the treatment of fibrosis. With a total of three patents to her name, her work focuses on innovative methods to improve lung function in patients suffering from pulmonary fibrosis.

Latest Patents

Anita's latest patents include groundbreaking methods for treating fibrosis. These methods and compositions specifically target pulmonary fibrosis, which may be idiopathic or arise following a lung infection, such as that caused by SARS-CoV-2. Her research indicates that lung function stabilizes or improves as a result of her treatment methods.

Career Highlights

Anita is currently associated with Endeavor Biomedicines, Inc., where she continues to develop her innovative approaches to treating fibrosis. Her dedication to advancing medical science has positioned her as a key figure in her field.

Collaborations

Anita collaborates with notable colleagues, including Miguel De Los Rios and John Hood. Their combined expertise enhances the research and development efforts at Endeavor Biomedicines, Inc.

Conclusion

Anita Difrancesco's work in the treatment of fibrosis exemplifies the impact of innovation in medicine. Her patents and ongoing research contribute significantly to improving patient outcomes in pulmonary health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…